Make your own free website on Tripod.com

QUINIDINE GLUCONATE

 

QUINIDINE POLYGALACTURONATE

 

QUINIDINE SULFATE

 

QUINIDINE GLUCONATE

Common Tradename
QUINAGLUTE DURA-TABS
Class
antiarrhythmic, group ia
Dosage, Adult (usual)
324-648mg PO Q8-12H
10mg/min IV infusion up to 400mg
Dosage, Pediatric, (usual)
PO children under 12 years 15mg/kg/day (divided BID- TID)
PO children over 12 years 10mg/kg/day (divided BID-TID)
Dose Adjustments:
liver disease, renal impairment
How Supplied
80 MG/ML SOLUTION FOR INJECTION
324 MG SUSTAINED-RELEASE TABLET
Indications
arrhythmias
Contraindications
hypersensitivity to quinidine
heart block
conduction defects
absence of atrial activity
dig intoxication
myasthenia gravis
Adverse Effects
myelosuppression
arrhythmias
SLE
N/V
diarrhea
Drug Interactions
acetazolamide
amiloride
amiodarone
amitriptyline
amoxapine
amprenavir
arbutamine
aspirin
atenolol
atracurium
aurothioglucose
bepridil
bornaprine
cimetidine
cisapride
cisatracurium
clomipramine
dalfopristin
decamethonium
delavirdine
desipramine
dextromethorphan
dicumarol
digitoxin
digoxin
diltiazem
disopyramide
distigmine
dofetilide
dolasetron
dothiepin
doxepin
erythromycin
fosphenytoin
gallamine
gatifloxacin
grepafloxacin
halofantrine
haloperidol
ibutilide
imipramine
itraconazole
ketoconazole
levofloxacin
levomethadyl
lofepramine
magaldrate
magnesium carbonate
magnesium hydroxide
magnesium oxide
magnesium trisilicate
mesoridazine
metformin
metoprolol
moxifloxacin
nelfinavir
nifedipine
nilvadipine
nisoldipine
nortriptyline
pancuronium
phenobarbital
phenytoin
pimozide
pipecuronium
procainamide
propafenone
propranolol
protriptyline
quinupristin
rapacuronium
rifampin
ritonavir
sotalol
sparfloxacin
succinylcholine
timolol
trimipramine
tubocurarine
vecuronium
verapamil
warfarin
Pregnancy Category
C
Breast Feeding
unknown

REFERENCE: MICROMEDEX(R) Healthcare Series Vol. 111 expires 3/2002

DESIGNED BY HASHIM TAYEB (Bsc PHARM)

QUINIDINE POLYGALACTURONATE

Common Tradename
CARDIOQUIN
Class
cinchona alkaloid
Dosage, Adult (usual)
arrhythmias PO 275-550mg Q6-8H
Dosage, Pediatric, (usual)
PO children under 12years 15mg/kg/day (divided Q6H-Q8H)
PO children over 12years 10mg/kg/day (divided Q6H-Q8H)
Dose Adjustments:
renal impairment
liver disease
How Supplied
275 MG TABLET
Indications
ventricular arrhythmias
supraventricular arrhythmias
Contraindications
hypersensitivity to quinidine products
complete AV dissociation or heart block
intraventricular conduction defects
absence of atrial activity
myasthenia gravis
Adverse Effects
myelosuppression
arrhythmias
systemic lupus erythematosus
N/V
diarrhea
Drug Interactions
acetazolamide
amiloride
amiodarone
amitriptyline
amoxapine
amprenavir
arbutamine
aspirin
atenolol
atracurium
aurothioglucose
bepridil
bornaprine
cimetidine
cisapride
cisatracurium
clomipramine
dalfopristin
decamethonium
delavirdine
desipramine
dextromethorphan
dicumarol
digitoxin
digoxin
diltiazem
disopyramide
distigmine
dofetilide
dolasetron
dothiepin
doxepin
erythromycin
fosphenytoin
gallamine
gatifloxacin
grepafloxacin
halofantrine
haloperidol
ibutilide
imipramine
itraconazole
ketoconazole
levofloxacin
levomethadyl
lofepramine
magaldrate
magnesium carbonate
magnesium hydroxide
magnesium oxide
magnesium trisilicate
mesoridazine
metformin
metoprolol
moxifloxacin
nelfinavir
nifedipine
nilvadipine
nisoldipine
nortriptyline
pancuronium
phenobarbital
phenytoin
pimozide
pipecuronium
procainamide
propafenone
propranolol
protriptyline
quinupristin
rapacuronium
rifampin
ritonavir
sotalol
sparfloxacin
succinylcholine
timolol
trimipramine
tubocurarine
vecuronium
verapamil
warfarin
Pregnancy Category
C
Breast Feeding
unknown

REFERENCE: MICROMEDEX(R) Healthcare Series Vol. 111 expires 3/2002

DESIGNED BY HASHIM TAYEB (Bsc PHARM) 

QUINIDINE SULFATE

Common Tradename
QUINIDEX EXTENTABS
Class
antiarrhythmic, group ia
Dosage, Adult (usual)
PO 200-400mg Q4-6H, or SR 300-600mg Q8-12H
Dosage, Pediatric, (usual)
PO 3-5mg/kg/dose Q3H x 3 doses, then 15-60mg/kg/24 hrs in 3-5 divided doses
Dose Adjustments:
liver disease, renal impairment
How Supplied
190 MG/ML SOLUTION FOR INJECTION
300 MG SUSTAINED-RELEASE TABLET
100 MG, 200 MG, 300 MG TABLET
Indications
arrhythmias
Contraindications
hypersensitivity to quinidine
complete heart block
absence of atrial activity
digitalis toxicity
myasthenia gravis
Adverse Effects
myelosuppression
N/V
diarrhea
Drug Interactions
acetazolamide
amiloride
amiodarone
amitriptyline
amoxapine
amprenavir
arbutamine
aspirin
atenolol
atracurium
aurothioglucose
bepridil
bornaprine
cimetidine
cisapride
cisatracurium
clomipramine
dalfopristin
decamethonium
delavirdine
desipramine
dextromethorphan
dicumarol
digitoxin
digoxin
diltiazem
disopyramide
distigmine
dofetilide
dolasetron
dothiepin
doxepin
erythromycin
fosphenytoin
gallamine
gatifloxacin
grepafloxacin
halofantrine
haloperidol
ibutilide
imipramine
itraconazole
ketoconazole
levofloxacin
levomethadyl
lofepramine
magaldrate
magnesium carbonate
magnesium hydroxide
magnesium oxide
magnesium trisilicate
mesoridazine
metformin
metoprolol
moxifloxacin
nelfinavir
nifedipine
nilvadipine
nisoldipine
nortriptyline
pancuronium
phenobarbital
phenytoin
pimozide
pipecuronium
procainamide
propafenone
propranolol
protriptyline
quinupristin
rapacuronium
rifampin
ritonavir
sotalol
sparfloxacin
succinylcholine
timolol
trimipramine
tubocurarine
vecuronium
verapamil
warfarin
 
Pregnancy Category
C
Breast Feeding
unknown

REFERENCE: MICROMEDEX(R) Healthcare Series Vol. 111 expires 3/2002

DESIGNED BY HASHIM TAYEB (Bsc PHARM)